A protocol has been developed which decreases the time for administrat
ion of N-nitrosopyrrolidine (NPYR) to male Syrian golden hamsters from
25 weeks to a single i.p. injection. Animals were divided into five g
roups: group I received two 0.5-mmol doses on alternate days; group II
was given three 0.33-mmol doses on alternate days; group III received
a single dose of 0.5 mmol; group IV was given a single dose of 0.25 m
mol and group V served as a control and received saline. Preneoplastic
and neoplastic changes in the upper respiratory tract and liver were
observed in all carcinogen-treated groups. The number of animals with
laryngeal and tracheal tumors in the NPYR-treated groups was dose-depe
ndent. Groups I and II, respectively, had 21 of 26 (81%) and 18 of 24
(75%) animals with either laryngeal or tracheal tumors. Groups III and
IV showed 4 of 12 (33%) and 3 of 13 (23%) hamsters with these tumors.
No laryngeal or tracheal tumors were observed in control animals. The
se results indicate that a single dose of NPYR is sufficient to induce
respiratory tract tumors in Syrian golden hamsters.